Civitas Solutions Acquires Three Massachusetts Adult Day Health (ADH) Centers
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
UBS Remains Bullish as Civitas Solutions (CIVI) Reaffirms Full Year Guidance
February 10, 2016 10:09 AM ESTUBS maintained a Buy rating on Civitas Solutions (NYSE: CIVI), and cut the price target to $28.00 (from $29.50), following the company's 1Q earnings report. CIVI posted adjusted EBITDA down to $36.3 mln, which was $1.8 mln below consensus' estimates. Adjusted EPS was $0.16, which compares to UBS' estimate of $0.20. CIVI kept full year guidance unchanged.
Analyst A.J. Rice commented, "CIVI posted F1Q16 adj EBITDA down 10.4% Y/Y to $36.3 mln,... More
